October 28th, 2022 – South San Francisco, CA by ESC Correspondent, Allie Saults The picture to the right is an artist’s rendering of another new development approved and planned for 100 E. Grand Ave. at Sylvester Road, which includes two…
Tag: biopharmaceutical
Biocom California Statement on New Drug Pricing Legislation
South San Francisco, CA August 8, 2022 Press Release Note: As South San Francisco boasts the recognition of being the birthplace of biotechnology and home to one of the largest consolidations of life science businesses, this press release is important…
Pliant Therapeutics Announces Proposed Public Offering of Common Stock
South San Francisco, CA July 12, 2022 Press Release Pliant Therapeutics, Inc. (Nasdaq: PLRX), a clinical stage biotechnology company focused on discovering and developing novel therapeutics for the treatment of fibrosis, today announced that it has commenced an underwritten public offering of…
Genentech Provides Update on Phase III SKYSCRAPER-02 Study in Extensive-Stage Small Cell Lung Cancer
South San Francisco, CA March 31, 2022 Press Release SKYSCRAPER-02, the first randomized study of tiragolumab in extensive-stage small cell lung cancer (ES-SCLC), did not meet its co-primary endpoint of progression-free survival ES-SCLC is a hard-to-treat disease and Tecentriq plus…
Golden Gate Produce Terminal to Revamp to Include More Biotech – Life Science Industry
South San Francisco, CA September 7, 2021 The San Francisco Business Times has provided an overview of the potential opportunities at the Golden Gate Produce Terminal and Park-n-Fly, off of Highway 101, in South San Francisco as they seek a…
CDC and FDA Recommend ‘Pause’ in Johnson and Johnson COVID Vaccine
South San Francisco, CA April 13, 2021 from CDC CDC and FDA have recommended a pause in the use of the Johnson & Johnson’s Janssen COVID-19 vaccine in the United States out of an abundance of caution, effective Tuesday, April…
Genentech Presents Data from Studies in Spinal Muscular Atrophy at the 2019 AAN Annual Meeting
South San Francisco, CA May 7, 2019 Genentech Press Release Genentech Presents Data from the Risdiplam Pivotal FIREFISH and SUNFISH Studies in Spinal Muscular Atrophy at the 2019 AAN Annual Meeting In the dose-finding Part 1 of FIREFISH, infants with…
New Genentech Data at the 2019 AAN Annual Meeting Showcase Breadth and Promise of Neuroscience Portfolio
South San Francisco, CA April 29, 2019 Genentech Press Release Risdiplam data from Part 1 of pivotal FIREFISH study show infants with Type 1 spinal muscular atrophy achieve key motor milestones and improved survival after one year of treatment New…
Genentech Submits Supplemental Biologics License Application to FDA; Breast Cancer
South San Francisco, CA February 8, 2019 Genentech Press Release Genentech Submits Supplemental Biologics License Application to FDA For Kadcyla for Adjuvant Treatment of People With HER2-Positive Early Breast Cancer With Residual Disease After Neoadjuvant Treatment — Application is being…
Cancer Research Institute Celebrates Sixth Annual Cancer Immunotherapy Month™ in June
South San Francisco, CA June 21, 2018 by Cancer Research Institute 30 days of education and awareness programming for patients, caregivers, and the public about cancer immunotherapy and clinical trials Join in #WearWhite Day on Friday, June 15, our signature…